Voglicose GM 0.3

Voglicose GM 0.3

Voglicose GM 0.3

Voglicose GM 0.3

Composition

Each Uncoated Bi-layered Tablet Contains: - Voglibose 0.3mg + Glimepiride 2mg + Metformin 500mg in Extended-Release form

Indication

Voglibose + Glimepiride + Metformin is a combination of medicines belonging to the class of anti-diabetic drugs. It is primarily prescribed for the management of type 2 diabetes mellitus in adults. This unique blend works through a multi-pronged approach to effectively control high blood glucose levels, especially after meals, which is crucial in preventing the long-term complications of diabetes.

The formulation in Voglicose GM 0.3 tablets combines the benefits of voglibose, glimepiride and metformin HCl (ER) tablets. In this combination, voglibose 0.3mg + metformin 500mg + glimepiride 2mg work synergistically to manage blood sugar levels. Voglibose helps slow down the breakdown and absorption of carbohydrates in the intestine, preventing sudden spikes in blood sugar after eating. Glimepiride stimulates the pancreas to release more insulin, enabling the body to use glucose efficiently. Metformin reduces glucose production in the liver and improves insulin sensitivity.

By lowering blood glucose levels, Voglicose GM 0.3 tablet therapy plays a vital role in reducing the risk of serious diabetes-related complications, including kidney damage (diabetic nephropathy), eye damage (diabetic retinopathy), nerve problems (neuropathy), and even limb amputation caused by poor circulation. Additionally, for individuals with type 2 diabetes who already have cardiovascular disease, consistent use of Voglicose GM 0.3 tab can help reduce the risk of heart attacks, strokes, and other heart-related complications.

As part of a comprehensive diabetes care plan that includes a balanced diet, regular exercise, and blood sugar monitoring, Voglicose GM 0.3 tablets can help maintain optimal glycemic control, improve health, and enhance quality of life.

Contraindication

Nausea, Diarrhoea, Abdominal pain, Hypoglycaemia, Loss of appetite.

Storage

Cool & Dry Place

Dosage

As directed by a Medical Practitioner or Physician.

Inquire Now
whatsapp-icon